Evidence map›Paper›PMID 37649004›Full record

ArticleBMC emergency medicine2023

Real world safety of methoxyflurane analgesia in the emergency setting: a comparative hybrid prospective-retrospective post-authorisation safety study.

Nawab Qizilbash, Himanshu Kataria, Heather Jarman, Ben Bloom, Michelle Bradney, Maggie Oh, Sue Anne Yee, Ana Roncero, Ignacio Mendez, Stuart Pocock

Open access · goldAbstract readComparative Study
In one paragraph

Article in BMC emergency medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 2 countries.

Nawab QizilbashOXON Epidemiology, London, UK. n.qizilbash@oxonepi.com.
Himanshu KatariaSt Helens and Knowsley NHS Foundation Trust (Whiston Hospital), Prescot, UK.
Heather JarmanSt Georges Hospital NHS Foundation Trust, London, UK.
Ben BloomBarts Health NHS Trust, London, UK.
Michelle BradneyMedical Developments International Limited, Victoria, Australia.
Maggie OhMedical Developments International Limited, Victoria, Australia.
Sue Anne YeeMedical Developments International Limited, Victoria, Australia.
Ana RonceroOXON Epidemiology, London, UK.
Ignacio MendezOXON Epidemiology, London, UK.
Stuart PocockLondon School of Hygiene & Tropical Medicine, London, UK.
Medical Developments International (Australia) · AUMRC Epidemiology Unit · GBBarts Health NHS Trust · GBLondon School of Hygiene & Tropical Medicine · GBSt George's Hospital · GBSt Helens and Knowsley Teaching Hospitals NHS Trust · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLow-dose analgesic methoxyflurane (Penthrox

methodsThis was a comparative hybrid prospective-retrospective cohort study. The comparative cohorts consisted of adults who were given methoxyflurane (methoxyflurane cohort) or another analgesic (concurrent cohort) routinely used for moderate to severe trauma and associated pain in the emergency setting (ambulance and Emergency Department) in the UK between December 2016 and November 2018. Hepatic and renal events were captured in the ensuing 12 weeks. A blinded clinical adjudication committee assessed events. A historical comparator cohort (non-concurrent cohort) was identified from patients with fractures in the English Hospital Episode Statistics (HES) accident and emergency database from November 2013 and November 2015 (before commercial launch of methoxyflurane). Hepatic and renal events were captured in the ensuing 12 weeks via linkage with the Clinical Practice Research Datalink (CPRD) and HES hospital admissions databases.

resultsOverall, 1,236, 1,101 and 45,112 patients were analysed in the methoxyflurane, concurrent and non-concurrent comparator cohorts respectively. There was no significant difference in hepatic events between the methoxyflurane and concurrent cohorts (1.9% vs. 3.0%, P = 0.079) or between the methoxyflurane and non-concurrent cohorts (1.9% vs. 2.5%, P = 0.192). Renal events were significantly less common in the methoxyflurane cohort than in the concurrent cohort (2.3% vs. 5.6%, P < 0.001). For methoxyflurane versus non-concurrent cohort the lower occurrence of renal events (2.3% vs. 3.2%, P = 0.070) was not statistically significant. Multivariable adjustment did not change these associations.

conclusionsMethoxyflurane administration was not associated with an increased risk of hepatotoxicity or nephrotoxicity compared with other routinely administered analgesics and was associated with a reduced risk of nephrotoxicity compared with other routinely administered analgesics.

trial registrationStudy registered in the EU PAS Register (ENCEPP/SDPP/13040).

Indexed as

AnalgesiaAnesthetics, InhalationChemical and Drug Induced Liver InjuryKidney DiseasesMethoxyfluraneAdultEmergenciesHumansIncidenceMaleMiddle AgedProspective StudiesRetrospective StudiesRiskAnesthetics, InhalationMethoxyfluraneAnalgesiaEmergency departmentHepatotoxicityNephrotoxicitySafety

Identifiers

PMID37649004
PMCPMC10469512
OpenAlexW4386285177

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.